The PubMed record identifies a review titled “From prophylaxis to precision immunotherapy via engineering vaccine platforms.” The title signals a broad thematic range, connecting conventional prophylaxis with targeted precision immunotherapy through engineered vaccine platforms. The source material available here is the PubMed entry; it lists article type, authors, affiliations, journal citation, PMID, and DOI. The entry does not reproduce the article abstract or its internal subsections, so the discussion below restricts itself to what the PubMed record reports and to transparent statements about what the source did not provide.
Gustavo Cabral-Miranda appears as the first author and corresponding contact in the PubMed entry. The record lists multiple coauthors and detailed institutional affiliations. Those affiliations span the University of São Paulo (laboratories of genetics, molecular cardiology, infectious diseases, immunology), the Federal University of Bahia, the Federal University of Rio Grande do Norte, and research institutes such as D'OR Institute for Research. The PubMed page presents full affiliation lines for each author; readers who need institutional context or to contact authors should use those lines as provided.
The record classifies the work as a Review in Mol Biomed, volume 7(1):259, with a publication date shown as 2026 Nov 22. The PubMed identifier (PMID) is 43067622 and the DOI is 10.1186/s43556-026-00674-3. These bibliographic details are provided on the page and are suitable for citation or literature searches. The PubMed entry also contains links to the full-text source where available and to related indexing resources.
Based on the title and the article type, investigators reported a synthesis focused on the engineering aspects of vaccine platforms and on transitioning concepts from prophylactic use to tailored immunotherapies. The PubMed listing designates the item as a Review, which implies a literature-based synthesis rather than primary clinical trial reporting. The source did not include the review’s structure or section headings; therefore, specific topics covered—such as platform types, molecular design strategies, delivery systems, or clinical translation pathways—were not enumerated in the provided material. Readers should consult the full text for the authors’ explicit thematic breakdown and evidence summaries.
The PubMed excerpt supplies full author names, institutional affiliations, article metadata, and indexing information. The page shows that this is a peer-reviewed Review article. However, the provided source text did not include the abstract content, detailed findings, comparative analyses, mechanistic data, or any numerical results. The record also references sections such as Conflict of interest statement and References on the PubMed page, but those sections were not reproduced in the excerpt shared here. The PubMed entry therefore confirms publication and authorship but does not permit extraction of specific scientific claims or methodological details from the review itself.
For clinicians, researchers, or formulary reviewers who require concrete experimental details—platform constructs, antigen design, adjuvant choices, preclinical or clinical data, endpoints, or dosing regimens—the PubMed listing in this source does not provide those elements. The review’s full text (journal website or publisher link via the DOI) should be consulted to obtain complete methods, summarized evidence, and any tables or figures the authors provided. The PubMed page includes links that can lead to the full article and to additional metadata such as MeSH terms, substances, grants, and the reference list; those resources will be necessary to evaluate translational applicability or to extract reproducible technical details.
Limitations documented in the provided source: the PubMed record excerpt available here omits the article abstract and all substantive review content, so no clinical outcomes, comparative efficacy statements, mechanistic claims, or experimental parameters can be quoted from this source. The manuscript is identified as a Review, and bibliographic data are complete; beyond that, the specific scientific content must be read in the full-text article available through the journal or DOI link.